Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 2
1985 1
1988 1
1989 3
1990 5
1991 2
1992 10
1993 9
1994 6
1995 14
1996 15
1997 13
1998 20
1999 26
2000 19
2001 26
2002 27
2003 23
2004 32
2005 25
2006 17
2007 12
2008 16
2009 19
2010 49
2011 42
2012 67
2013 51
2014 83
2015 73
2016 106
2017 89
2018 96
2019 92
2020 121
2021 158
2022 138
2023 119
2024 39

Text availability

Article attribute

Article type

Publication date

Search Results

1,490 results

Results by year

Filters applied: . Clear all
Page 1
Beta-Blocker Therapy in Severe Traumatic Brain Injury: A Prospective Randomized Controlled Trial.
Khalili H, Ahl R, Paydar S, Sjolin G, Cao Y, Abdolrahimzadeh Fard H, Niakan A, Hanna K, Joseph B, Mohseni S. Khalili H, et al. World J Surg. 2020 Jun;44(6):1844-1853. doi: 10.1007/s00268-020-05391-8. World J Surg. 2020. PMID: 32002583 Clinical Trial.
No significant difference in in-hospital mortality (adj. IRR 0.6 [95% CI 0.3-1.4], p = 0.2) or long-term functional outcome was measured between the cohorts (p = 0.3). ...IRR 0.32, p = 0.04) and functional outcome at 6-month follow-up (GOS-E 5 adj. ...
No significant difference in in-hospital mortality (adj. IRR 0.6 [95% CI 0.3-1.4], p = 0.2) or long-term functional outcome was measu …
P-tau231 as a Diagnostic Biomarker for Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.
Nabizadeh F, Salehi N, Ramezannezhad E, Sadeghmousavi S, Khalili E. Nabizadeh F, et al. Ann Indian Acad Neurol. 2022 Sep-Oct;25(5):845-851. doi: 10.4103/aian.aian_77_22. Epub 2022 Oct 31. Ann Indian Acad Neurol. 2022. PMID: 36560987 Free PMC article.
RESULTS: A total of 10 studies including 1141 subjects were included. The present study showed that CSF level of p-tau231 was significantly higher in AD patients compared to that in MCI patients (SMD = 160.94 [11.11, 310.78], P = 0.04) and NC patients (SMD = 436.21 …
RESULTS: A total of 10 studies including 1141 subjects were included. The present study showed that CSF level of p-tau231 was signifi …
Risk factors for post-traumatic epilepsy.
Khalili H, Kashkooli NR, Niakan A, Asadi-Pooya AA. Khalili H, et al. Seizure. 2021 Jul;89:81-84. doi: 10.1016/j.seizure.2021.05.004. Epub 2021 May 13. Seizure. 2021. PMID: 34023655 Free article.
A higher Glasgow outcome scale (extended) at discharge was significantly inversely associated with PTE [Odds Ratio (OR)= 0.76, 95% Confidence Interval (CI): 0.65-0.87; p = 0.0001]. Depressed skull fracture (OR= 1.88, 95% CI: 0.92-3.80; p = 0.081), epi-dural hematoma …
A higher Glasgow outcome scale (extended) at discharge was significantly inversely associated with PTE [Odds Ratio (OR)= 0.76, 95% Confidenc …
Organizing pneumonia-like pattern in COVID-19.
Raoufi M, Kahkooei S, Haseli S, Robatjazi F, Bahri J, Khalili N. Raoufi M, et al. Adv Respir Med. 2021 Oct 6. doi: 10.5603/ARM.a2021.0081. Online ahead of print. Adv Respir Med. 2021. PMID: 34612508 Free article.
RESULTS: Duration from symptom onset to presentation was significantly higher in the OP group (7.07 3.71 versus 6.13 4.96 days, p = 0.008). A higher COVID-19-related mortality rate was observed among patients with OP-like pattern (17.5% vs 3.7%, p = 0.001).There was …
RESULTS: Duration from symptom onset to presentation was significantly higher in the OP group (7.07 3.71 versus 6.13 4.96 days, p = 0 …
Effect of intra-ovarian platelet rich plasma in women with poor ovarian response.
Davari Tanha F, Salimi Setudeh S, Ebrahimi M, Feizabad E, Khalaj Sereshki Z, Akbari Asbagh F, Pakniat H, Khalili A, Kaveh Z, Saeedi S. Davari Tanha F, et al. Caspian J Intern Med. 2023 Summer;14(3):485-489. doi: 10.22088/cjim.14.3.485. Caspian J Intern Med. 2023. PMID: 37520871 Free PMC article.
After PRP injection, follicle-stimulating hormone levels dropped about 1% (P=0.499), anti-Mullerian hormone levels were on average 4.5% higher (P=0.356), and estradiol levels raised by 1.2% (P=0.681). The average number of oocytes and their quality increased …
After PRP injection, follicle-stimulating hormone levels dropped about 1% (P=0.499), anti-Mullerian hormone levels were on average 4. …
Comparison of Endogenous Endophthalmitis in Patients with and Without COVID-19 Infection.
Namvar E, Moallem M, Afarid M, Bolkheir A. Namvar E, et al. J Ophthalmol. 2022 Nov 15;2022:6284569. doi: 10.1155/2022/6284569. eCollection 2022. J Ophthalmol. 2022. PMID: 36425881 Free PMC article.
Follow-ups ranged from 1 month to 20 months (mean, 8 months). There were no statistically significant differences in age (P = 0.653), mean follow-up (P = 0.943), gender (P = 0.313), and clinical presentation (P = 0.409) between the case and control gro …
Follow-ups ranged from 1 month to 20 months (mean, 8 months). There were no statistically significant differences in age (P = 0.653), …
Predicting protein phosphorylation sites in soybean using interpretable deep tabular learning network.
Khalili E, Ramazi S, Ghanati F, Kouchaki S. Khalili E, et al. Brief Bioinform. 2022 Mar 10;23(2):bbac015. doi: 10.1093/bib/bbac015. Brief Bioinform. 2022. PMID: 35152280
The experimentally verified p-sites data of soybean proteins are collected from the eukaryotic phosphorylation sites database and database post-translational modification. ...The proposed technique can automatically analyze the data without any measurement errors and any h …
The experimentally verified p-sites data of soybean proteins are collected from the eukaryotic phosphorylation sites database and dat …
1,490 results